Skip to main content
SpringerLink
Log in

Clinical manifestation of cancer related stroke: retrospective case–control study

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Cancer related stroke may have different phenotypes from non-cancer stroke, especially in terms of stroke progression and recurrence. We performed a case–control study to identify their incidences and risk factors in cancer related stroke. Between January 2001 and December 2009, we conducted a retrospective review of acute ischemic stroke patients with cancer who were admitted to Seoul National University Hospital, Seoul, Korea. The stroke patients without cancer served as control. We collected demographic variables, vascular risk factors, stroke phenotype, clinical course, and cancer information including diagnosis, stage, and treatment status. Among cancer stroke patients, the potential risk factor of stroke recurrence was evaluated. The mean age of the 102 cancer patients was 66.4 ± 10.8 years, and 64.7 % were men. The mean time interval from cancer diagnosis to stroke onset was 39.7 ± 60.9 months. The principal lesion pattern of cancer stroke was multiple dots extending single vascular territory (39.2 %), and they were associated with low hemoglobin and high fibrinogen levels. Stroke progression and recurrence were noted in 9.8 and 27.5 % of cancer stroke patients, and in 9.3 and 12.7 % of control patients, respectively. The stroke subtype was independently associated with recurrence of cancer stroke after multiple logistic regression (odds ratio = 3.165, 95 % confidence interval = 1.080–9.277, p = 0.036). Cancer related stroke has a distinct phenotype in terms of infarction pattern and laboratory findings. Stroke recurrence is frequently observed among cancer stroke patients, and its risk is related with stroke subtype.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Wen PY, Glantz MJ (2003) Neurologic complications of cancer. Preface. Neurol Clin 21:xi–xiii

    Article  PubMed  Google Scholar 

  2. Grisold W, Oberndorfer S, Struhal W (2009) Stroke and cancer: a review. Acta Neurol Scand 119:1–16

    Article  PubMed  CAS  Google Scholar 

  3. Rogers LR (2004) Cerebrovascular complications in patients with cancer. Semin Neurol 24:453–460

    Article  PubMed  Google Scholar 

  4. Nguyen T, DeAngelis LM (2006) Stroke in cancer patients. Curr Neurol Neurosci Rep 6:187–192

    Article  PubMed  Google Scholar 

  5. Kwon HM, Kang BS, Yoon BW (2007) Stroke as the first manifestation of concealed cancer. J Neurol Sci 258:80–83

    Article  PubMed  Google Scholar 

  6. Zhang YY, Cordato D, Shen Q et al (2007) Risk factor, pattern, etiology and outcome in ischemic stroke patients with cancer: a nested case-control study. Cerebrovasc Dis 23:181–187

    Article  PubMed  CAS  Google Scholar 

  7. Taccone FS, Jeangette SM, Blecic SA (2008) First-ever stroke as initial presentation of systemic cancer. J Stroke Cerebrovasc Dis 17:169–174

    Article  PubMed  Google Scholar 

  8. Petty GW, Brown RD Jr, Whisnant JP et al (2000) Ischemic stroke subtypes: a population-based study of functional outcome, survival, and recurrence. Stroke 31:1062–1068

    Article  PubMed  CAS  Google Scholar 

  9. Sumer M, Ozdemir I, Erturk O (2003) Progression in acute ischemic stroke: frequency, risk factors and prognosis. J Clin Neurosci 10:177–180

    Article  PubMed  Google Scholar 

  10. Aho K, Harmsen P, Hatano S et al (1980) Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ 58:113–130

    PubMed  CAS  Google Scholar 

  11. Adams HP Jr, Bendixen BH, Kappelle LJ et al (1993) Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial TOAST Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35–41

    Article  PubMed  Google Scholar 

  12. Cestari DM, Weine DM, Panageas KS et al (2004) Stroke in patients with cancer: incidence and etiology. Neurology 62:2025–2030

    Article  PubMed  CAS  Google Scholar 

  13. Kim SG, Hong JM, Kim HY et al (2010) Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea. Stroke 41:798–801

    Article  PubMed  Google Scholar 

  14. Seok JM, Kim SG, Kim JW et al (2010) Coagulopathy and embolic signal in cancer patients with ischemic stroke. Ann Neurol 68:213–219

    PubMed  Google Scholar 

  15. Jung KW, Park S, Kong HJ et al (2011) Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat 43:1–11

    Article  PubMed  Google Scholar 

  16. Kreisl TN, Toothaker T, Karimi S et al (2008) Ischemic stroke in patients with primary brain tumors. Neurology 70:2314–2320

    Article  PubMed  Google Scholar 

  17. Huang WY, Chen IC, Meng L et al (2009) The influence of anemia on clinical presentation and outcome of patients with first-ever atherosclerosis-related ischemic stroke. J Clin Neurosci 16:645–649

    Article  PubMed  Google Scholar 

  18. Tanne D, Molshatzki N, Merzeliak O et al (2010) Anemia status, hemoglobin concentration and outcome after acute stroke: a cohort study. BMC Neurol 10:22

    Article  PubMed  Google Scholar 

  19. Irace C, Ciamei M, Crivaro A et al (2003) Hematocrit is associated with carotid atherosclerosis in men but not in women. Coron Artery Dis 14:279–284

    PubMed  Google Scholar 

  20. Adams RJ, McKie VC, Hsu L et al (1998) Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results of transcranial Doppler ultrasonography. N Engl J Med 339:5–11

    Article  PubMed  CAS  Google Scholar 

  21. Lee MT, Piomelli S, Granger S, STOP Study Investigators et al (2006) Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results. Blood 108:847–852

    Article  PubMed  CAS  Google Scholar 

  22. Tsuda Y, Satoh K, Kitadai M et al (1997) Hemorheologic profiles of plasma fibrinogen and blood viscosity from silent to acute and chronic cerebral infarctions. J Neurol Sci 147:49–54

    Article  PubMed  CAS  Google Scholar 

  23. Audebert HJ, Pellkofer TS, Wimmer ML et al (2004) Progression in lacunar stroke is related to elevated acute phase parameters. Eur Neurol 51:125–131

    Article  PubMed  CAS  Google Scholar 

  24. Thanvi B, Treadwell S, Robinson T (2008) Early neurological deterioration in acute ischaemic stroke: predictors, mechanisms and management. Postgrad Med J 84:412–417

    Article  PubMed  CAS  Google Scholar 

  25. Hillen T, Coshall C, Tilling K et al (2003) Cause of stroke recurrence is multifactorial: patterns, risk factors, and outcomes of stroke recurrence in the South London stroke register. Stroke 34:1457–1463

    Article  PubMed  Google Scholar 

  26. Davalos A, Toni D, Lweins F et al (1999) Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European cooperative acute stroke study (ECASS) I. Stroke 30:2631–2636

    Article  PubMed  CAS  Google Scholar 

  27. Ay H, Gungor L, Arsava EM et al (2010) A score to predict early risk of recurrence after ischemic stroke. Neurology 74:128–135

    Article  PubMed  CAS  Google Scholar 

  28. Jackson CA, Hutchison A, Dennis MS et al (2009) Differences between ischemic stroke subtypes in vascular outcomes support a distinct lacunar ischemic stroke arteriopathy: a prospective, hospital-based study. Stroke 40:3679–3684

    Article  PubMed  Google Scholar 

  29. Soda T, Nakayasu H, Maeda M et al (2004) Stroke recurrence within the first year following cerebral infarction—Tottori University Lacunar Infarction Prognosis Study (TULIPS). Acta Neurol Scand 110:343–349

    Article  PubMed  Google Scholar 

  30. Lovett JK, Coull AJ, Rothwell PM (2004) Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 62:569–573

    Article  PubMed  CAS  Google Scholar 

  31. Falanga A, Marchetti M (2012) Anticancer treatment and thrombosis. Thromb Res 129:353–359

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A110045).

Author information

Authors and Affiliations

  1. Stroke & Stem Cell Laboratory, Department of Neurology, Clinical Research Institute, Seoul National University Hospital, 28, Yongon-dong, Chongro-gu, Seoul, 110-744, South Korea

    Jeong-Min Kim, Keun-Hwa Jung, Kee Hong Park, Soon-Tae Lee, Kon Chu & Jae-Kyu Roh

Authors
  1. Jeong-Min Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Keun-Hwa Jung
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kee Hong Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Soon-Tae Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kon Chu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jae-Kyu Roh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jae-Kyu Roh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, JM., Jung, KH., Park, K.H. et al. Clinical manifestation of cancer related stroke: retrospective case–control study. J Neurooncol 111, 295–301 (2013). https://doi.org/10.1007/s11060-012-1011-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-012-1011-4

Keywords

Search

Navigation